Immunogenicity during 6 months after SARS-CoV-2 infection is significantly different depending on previous COVID-19 vaccine regimens and a booster dose received.

导出 LinkOut

翻译打印收藏纠错

作者： Paskorn,Sritipsukho ^[1] ; Pakatip,Sinlapamongkolkul ^[2] ; Araya,Satdhabudha ^[2] ; Chanapai,Chaiyakulsil ^[2] ; Surakameth,Mahasirimongkol ^[3] ; Waritta,Sawaengdee ^[4] ; Waraphorn,Fukpho ^[5] ; Thana,Khawcharoenporn ^[6]

作者单位： Center of Excellence in Applied Epidemiology, Thammasat University, Thailand; Department of Pediatrics, Faculty of Medicine, Thammasat University, Thailand; Research Group in Clinical Epidemiology, Faculty of Medicine, Thammasat University, Thailand. ^[1] Department of Pediatrics, Faculty of Medicine, Thammasat University, Thailand; Research Group in Pediatrics, Faculty of Medicine, Thammasat University, Thailand. ^[2] Genomic Medicine Center, Department of Medical Sciences, Ministry of Public Health, Thailand. ^[3] Medical Life Sciences Institute, Department of Medical Sciences, Ministry of Public Health, Thailand. ^[4] Medical Technology Laboratory of Thammasat University Hospital, Thammasat University, Thailand. ^[5] Center of Excellence in Applied Epidemiology, Thammasat University, Thailand; Infectious Diseases Unit, Department of Internal Medicine, Faculty of Medicine, Thammasat University, Thailand. Electronic address: kthana@tu.ac.th. ^[6]

关键词 Booster dose COVID-19 Immunogenicity SARS-CoV-2 Vaccine regimen